BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15694900)

  • 1. Screening for cervical cancer: will women accept less?
    Sirovich BE; Woloshin S; Schwartz LM
    Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
    Echeverria SE; Carrasquillo O
    Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pap smear screening in a health maintenance organization: 1986-1990.
    Rolnick S; LaFerla JJ; Wehrle D; Trygstad E; Okagaki T
    Prev Med; 1996; 25(2):156-61. PubMed ID: 8860280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    Sepúlveda C; Prado R
    Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
    Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of health insurance on Pap smear and mammography utilization by immigrants living in the United States.
    Carrasquillo O; Pati S
    Prev Med; 2004 Nov; 39(5):943-50. PubMed ID: 15475028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why worry about awareness in choice problems? Econometric analysis of screening for cervical cancer.
    Belkar R; Fiebig DG; Haas M; Viney R
    Health Econ; 2006 Jan; 15(1):33-47. PubMed ID: 16145719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer: how often--and why--to screen older women.
    Mandelblatt JS; Phillips RN
    Geriatrics; 1996 Jun; 51(6):45-8; quiz 49. PubMed ID: 8647475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study.
    Chen LS; Huang N; Tsay JH; Wang PJ; Chou YJ; Chou P; Lee CH
    Prev Med; 2007 Jun; 44(6):531-5. PubMed ID: 17467786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of patient comfort and adherence with less frequent cervical cancer screening.
    MacLaughlin KL; Angstman KB; Flynn PM; Schmitt JR; Weaver AL; Shuster LT
    Qual Prim Care; 2011; 19(6):355-63. PubMed ID: 22340898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
    Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
    Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.